SCHEMBL21692829

SCHEMBL21692829

N#Cc1ccc(-c2cc(-c3ccc4oc5ccccc5c4c3)cc(-c3ccc4oc5ccccc5c4c3)c2)cc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
MAPT P10636 3/20 0.44
NPC1 O15118 2/20 0.44
MEN1 O00255 2/20 0.44
HPGD P15428 2/20 0.44
KMT2A Q03164 2/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TNKS O95271 1/20 0.40
AHR P35869 2/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
HTT P42858 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
PLA2G2A P14555 4/20 0.40
PLA2G4A P47712 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21691279 0.91 AHR (0.44) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL21692722 0.89 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL23328471 0.88 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL25544532 0.88 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL16122083 0.87 KDM4E (0.43) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL21692031 0.86 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL21691248 0.86 PLA2G2A (0.42) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL21692154 0.86 PLA2G2A (0.42) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL21691255 0.86 PLA2G2A (0.44) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL21692814 0.85 KDM4E (0.43) ALDH1A1KDM4EMAPTNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALDH1A1 738/4885KDM4E 3679/4885MAPT 1412/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALDH1A1 738/4885KDM4E 3679/4885MAPT 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.